Form 4: Arcus Biosciences President Sells Shares

Sentiment:

Insider Transaction (Form 4)


Juan C. Jaen, President of Arcus Biosciences, Inc., sold 68,569 shares of common stock on July 9, 2026.

Summary

  • Open-market sale: disposed of 48,502 Common Stock at $30.05 ($1,457,631) on July 9, 2026; holds 842,307 after (Indirect).
  • Open-market sale: disposed of 19,799 Common Stock at $28.61 ($566,410) on July 10, 2026; holds 822,508 after (Indirect).
  • Open-market sale: disposed of 268 Common Stock at $29.40 ($7,878) on July 10, 2026; holds 822,240 after (Indirect).

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $2,031,919 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.

Insider Transactions

Juan C. Jaen — Officer (President)

Transaction made under a Rule 10b5-1 trading plan.

DateTransactionSecuritySharesPriceValueHeld After
2026-07-09Open-market saleCommon Stock48,502$30$1.5M842,307
2026-07-10Open-market saleCommon Stock19,799$29$566.4K822,508
2026-07-10Open-market saleCommon Stock268$29$7.9K822,240

Key Dates

DateDescription
2026-07-09Open-market sale (48,502 shares)
2026-07-10Open-market sale (19,799 shares)
2026-07-10Open-market sale (268 shares)

Keywords

insider transaction, Form 4, RCUS, Arcus Biosciences, Inc., bearish, Juan C. Jaen

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.